Slide Insurance Holdings heads into its April 29 Q1 earnings report with a striking insider selling pattern that stands out far more than its short positioning.
The headline is the selling. CEO Bruce Lucas has unloaded roughly $13.4 million worth of shares across three separate transactions since April 9, while COO Shannon Lucas and Chief Risk Officer Matt Larson have each trimmed positions in the same window. The net insider position over 90 days is a net sell of around $34 million. All three executives sold at prices between $18 and $19.55 — near current levels — which frames the stock's 7.5% monthly gain as a sell-the-rally rather than a vote of confidence going into the print.
Short interest tells a quieter story. Bears have been covering, not adding. Short interest as a percentage of free float has dropped roughly 55% from mid-April peaks near 9.5% of float back to 4.4% — a sharp reversal that suggests the most aggressive shorts have already stepped aside. Borrow conditions support that read: cost to borrow is just 0.65%, barely above its month-ago level, and the lending market remains comfortably loose. That picture contrasts sharply with the insider selling — positioning in the borrow market is relaxed, but the people who built the company are cashing out.
Options traders have tilted more defensive into the report. The put/call ratio has climbed to 0.66, running well above its 20-day average of 0.41 and 1.6 standard deviations above the norm — approaching its 52-week high of 0.79. That shift coincides with the insider sales becoming public knowledge and may reflect the market processing the signal. The stock itself is down marginally on the week at $18.87, even after a strong prior month.
The analyst community remains constructive. Barclays lifted its target to $29 after February's strong Q4 print, and both Piper Sandler and Keefe Bruyette maintained Overweight/Outperform ratings with raised targets following the same result. The mean target of $25.20 implies roughly 34% upside from current levels. The bull case centres on SLDE's 89% CAGR in gross premiums written from 2022–2024, favorable Florida legislative reforms, and geographic expansion into New York and New Jersey. Bears focus on reinsurance cost exposure: any material spike in reinsurance pricing cuts directly into margins in the hurricane-prone coastal markets where SLDE is most concentrated. At a P/E near 5.7x and P/B of 1.5x, valuation is not stretched — but those multiples assume manageable catastrophe losses.
The past two earnings prints produced outsized moves: the stock jumped 17% in a single session after Q3 results, then added another 10% after Q4. The Q1 report will test whether that momentum can persist in the face of coordinated insider distribution near current prices.
See the live data behind this article on ORTEX.
Open SLDE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
